COVID-19, impact on myeloma patients.

Dufour, Inès;Raedemaeker, Juliette;Andreozzi, Fabio;Verstraete, Géraldine;Vekemans, Marie-Christiane;et.al.
(2020) Annals of hematology — Vol. 99, n° 8, p. 1947-1949 (2020)

Files

2020_Dufour_Ann_Hematol.pdf
  • Open Access
  • Adobe PDF
  • 176.33 KB
Download

Details

Authors
Show more
Abstract
To the Editor: The worldwide COVID-19 pandemic is expected to be a devastating infection in patients with chronic hematological disorders. So far, no data have been reported in multiple myeloma (MM), a disease characterized by a severe humoral and cellular immune deficiency that exposes patients to infectious complications. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Dufour, I., Raedemaeker, J., Andreozzi, F., Verstraete, G., Bailly, S., Delforge, M., Storms, P., Jacquy, C., Van de Velde, A., Mineur, P., Lejeune, M., Bauwens, D., Van Obbergh, F., Kentos, A., Nguyen, J., Fostier, K., De Weweire, A., Meuleman, N., & Vekemans, M.-C. (2020). COVID-19, impact on myeloma patients. Annals of hematology, 99(8), 1947-1949. https://doi.org/10.1007/s00277-020-04147-7 (Original work published 2020)